425 related articles for article (PubMed ID: 17726407)
1. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen mL; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():S1-113. PubMed ID: 17726407
[No Abstract] [Full Text] [Related]
2. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
[No Abstract] [Full Text] [Related]
3. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Scholte op Reimer W; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A;
Eur Heart J; 2007 Oct; 28(19):2375-414. PubMed ID: 17726041
[No Abstract] [Full Text] [Related]
4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Perk J; De Backer G; Gohlke H; Graham I; Reiner Z; Verschuren M; Albus C; Benlian P; Boysen G; Cifkova R; Deaton C; Ebrahim S; Fisher M; Germano G; Hobbs R; Hoes A; Karadeniz S; Mezzani A; Prescott E; Ryden L; Scherer M; Syvänne M; Scholte op Reimer WJ; Vrints C; Wood D; Zamorano JL; Zannad F; ;
Eur Heart J; 2012 Jul; 33(13):1635-701. PubMed ID: 22555213
[No Abstract] [Full Text] [Related]
5. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
6. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
[TBL] [Abstract][Full Text] [Related]
7. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
9. [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].
Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney MT; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen ML; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
G Ital Cardiol (Rome); 2017; 18(7):547-612. PubMed ID: 28714997
[No Abstract] [Full Text] [Related]
10. Risk factor management: a practice guide.
Perk J
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
[No Abstract] [Full Text] [Related]
11. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019.
Précoma DB; Oliveira GMM; Simão AF; Dutra OP; Coelho OR; Izar MCO; Póvoa RMDS; Giuliano ICB; Alencar Filho AC; Machado CA; Scherr C; Fonseca FAH; Santos Filho RDD; Carvalho T; Avezum Á; Esporcatte R; Nascimento BR; Brasil DP; Soares GP; Villela PB; Ferreira RM; Martins WA; Sposito AC; Halpern B; Saraiva JFK; Carvalho LSF; Tambascia MA; Coelho-Filho OR; Bertolami A; Correa Filho H; Xavier HT; Faria-Neto JR; Bertolami MC; Giraldez VZR; Brandão AA; Feitosa ADM; Amodeo C; Souza DDSM; Barbosa ECD; Malachias MVB; Souza WKSB; Costa FAAD; Rivera IR; Pellanda LC; Silva MAMD; Achutti AC; Langowiski AR; Lantieri CJB; Scholz JR; Ismael SMC; Ayoub JCA; Scala LCN; Neves MF; Jardim PCBV; Fuchs SCPC; Jardim TSV; Moriguchi EH; Schneider JC; Assad MHV; Kaiser SE; Lottenberg AM; Magnoni CD; Miname MH; Lara RS; Herdy AH; Araújo CGS; Milani M; Silva MMFD; Stein R; Lucchese FA; Nobre F; Griz HB; Magalhães LBNC; Borba MHE; Pontes MRN; Mourilhe-Rocha R
Arq Bras Cardiol; 2019 Nov; 113(4):787-891. PubMed ID: 31691761
[No Abstract] [Full Text] [Related]
12. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.
Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
Sepúlveda C; Palomo I; Fuentes E
Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.
Kumar R; Brar J; Yacoub R; Khan T; Zachariah M; Venuto R
Transplant Proc; 2012 Jun; 44(5):1270-4. PubMed ID: 22663999
[TBL] [Abstract][Full Text] [Related]
15. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
[TBL] [Abstract][Full Text] [Related]
17. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
Robins SJ
Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
[TBL] [Abstract][Full Text] [Related]
18. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
19. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
Jialal I; Smith G
Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
[No Abstract] [Full Text] [Related]
20. Clinical approach to the inflammatory etiology of cardiovascular diseases.
Ruscica M; Corsini A; Ferri N; Banach M; Sirtori CR
Pharmacol Res; 2020 Sep; 159():104916. PubMed ID: 32445957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
